Akums Drugs and Pharmaceuticals Limited — Others, 11-02-2025: Monitoring Agency Report

Akums Drugs and Pharmaceuticals Limited has announced a board meeting to review the report from CRISIL Ratings Limited regarding the utilization of IPO proceeds for the quarter ended December 31, 2024. The monitoring report indicates that all proceeds are being utilized as per the offer document without deviations or delays in implementation. Specific applications of funds include repayment of debt and working capital needs, with no unutilized amounts reported for significant items. From an investor perspective, this reinforces a positive outlook on the company's financial health and adherence to its strategic objectives.